University of Heidelberg
BIOQUANT

01/26/2024 Open Position

The BMCV group currently offers a PhD position in biomedical image analysis.

More details can be...


03/01/2023 Publication in IEEE Transactions on Pattern Analysis and Machine Intelligence 2023

Our article "Superadditivity and Convex Optimization for Globally Optimal Cell Segmentation Using...


01/27/2018 Cell Tracking Challenge, Nature Methods 2017

The cell tracking method of the BMCV group yielded top-ranking results in an international...


07/13/2015 ISBI 2016

Karl Rohr is program chair of the IEEE International Symposium on Biomedical Imaging (ISBI) which...


11/10/2014 Project QuantVessel at Deutsche Bundestag (German Parliament)

The research project QuantVessel of the BMCV group is presented at an exhibition of the German...


Displaying results 1 to 5 out of 14

1

2

3

Next >

Latest News

Breaking News:

01/26/2024 10:00

Open Position

The BMCV group currently offers a PhD position in biomedical image analysis.

More details can be found here.


03/01/2023 12:37

Publication in IEEE Transactions on Pattern Analysis and Machine Intelligence 2023

Our article "Superadditivity and Convex Optimization for Globally Optimal Cell Segmentation Using Deformable Shape Models" has been published in IEEE...


Biomedical Computer Vision Group

The research group Biomedical Computer Vision (BMCV) develops methods and algorithms for computer-based analysis of biological and medical images, in particular, cell microscopy images. A main aim is to derive quantitative information about cellular structures, tissue, and organs based on multi-modal image data. Research topics are cell segmentation and tracking, particle detection and tracking, non-rigid image registration, vessel segmentation, and landmark localization using deep learning methods, model-based methods, and probabilistic methods.

 

The BMCV group belongs to Heidelberg University, BioQuant Center, IPMB, and the German Cancer Research Center (DKFZ).

 

Contact: E-Mail (Last update: 18/03/2024)